Found: 28
Select item for more details and to access through your institution.
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.
- Published in:
- Modern Pathology, 2005, v. 18, n. 4, p. 558, doi. 10.1038/modpathol.3800323
- By:
- Publication type:
- Article
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TRIAL BY FIRE: A HEALTH AUTHORITY'S EXPERIENCE OF THE CLIMATE EMERGENCY.
- Published in:
- Plan Canada, 2022, v. 62, n. 3, p. 8
- By:
- Publication type:
- Article
Wound Complications in Head and Neck Squamous Cell Carcinomas After Anti-PD-1 Therapy.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.
- Published in:
- Laryngoscope, 2017, v. 127, n. 7, p. 1583, doi. 10.1002/lary.26422
- By:
- Publication type:
- Article
Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies-results of a phase I dose-escalation study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1487, doi. 10.1007/s10637-013-0010-4
- By:
- Publication type:
- Article
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 1, p. 53, doi. 10.1007/s10637-008-9154-z
- By:
- Publication type:
- Article
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.
- Published in:
- Nature, 2011, v. 477, n. 7362, p. 99, doi. 10.1038/nature10358
- By:
- Publication type:
- Article
Biomarkers predictive of response to pembrolizumab in head and neck cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6603, doi. 10.1002/cam4.5434
- By:
- Publication type:
- Article
Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 1, p. i1, doi. 10.1093/neuonc/now197
- By:
- Publication type:
- Article
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase I trial to determine the safety, pharmacokinetics, and pharmacodynamics of intercalated BMS-690514 with paclitaxel/carboplatin (PC) in advanced or metastatic solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 5, p. 1273, doi. 10.1007/s00280-013-2126-9
- By:
- Publication type:
- Article
Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 2, p. 307, doi. 10.1007/s00280-012-2008-6
- By:
- Publication type:
- Article
A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 63, n. 1, p. 65, doi. 10.1007/s00280-008-0712-z
- By:
- Publication type:
- Article
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 4, p. 631, doi. 10.1007/s00280-007-0646-x
- By:
- Publication type:
- Article
Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 7, p. 1963, doi. 10.1002/ijc.32951
- By:
- Publication type:
- Article
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148764
- By:
- Publication type:
- Article
A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies.
- Published in:
- Head & Neck, 2018, v. 40, n. 3, p. 584, doi. 10.1002/hed.25020
- By:
- Publication type:
- Article
Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.
- Published in:
- Head & Neck, 2016, v. 38, n. 9, p. 1318, doi. 10.1002/hed.24437
- By:
- Publication type:
- Article
Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 329, doi. 10.1007/s11523-022-00891-0
- By:
- Publication type:
- Article
Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 11, p. 925, doi. 10.1002/onco.13911
- By:
- Publication type:
- Article
The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
- Published in:
- Oncologist, 2015, v. 20, n. 7, p. 812, doi. 10.1634/theoncologist.2014-0422
- By:
- Publication type:
- Article
An Unusual Case of Pulmonary Invasive Aspergillosis and Aspergilloma Cured with Voriconazole in a Patient with Cystic Fibrosis.
- Published in:
- Clinical Infectious Diseases, 2002, v. 35, n. 9, p. e106, doi. 10.1086/343743
- By:
- Publication type:
- Article
A phase I study of pazopanib in combination with escalating doses of <sup>131</sup>I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178325
- By:
- Publication type:
- Article